Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?

Part of paid clinical trials in El Paso, Texas.

Sponsor
Texas Tech University Health Sciences Center, El Paso
Study ID
NCT06016465
Phase
EARLY_PHASE1
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • Dexamethasone Oral — DRUG
    Two 4mg pills
  • Placebo — DRUG
    2 placebo pills

Study Details

For some patients who come to the emergency department for treatment of a migraine headache, peripheral headache nerve blocks (PHNB) have proven to be an efficient and effective treatment for headache relief. Previous studies have demonstrated that adding steroids as an adjunct treatment to standard migraine treatment can reduce recurrence of headaches in the subsequent few days.

Key Dates

Start date
Sep 15, 2023
Status verified
Apr 2026
Primary completion
Dec 30, 2027
Completion
Jan 30, 2028

Study Design

Enrollment
84 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Dexamethasone
    single oral dose of dexamethasone (8mg)
  • Placebo Comparator: Placebo
    Single oral dose of placebo pill

Primary Outcome Measure

Recurrence of headache [ Time Frame: 72-96 hours post treatment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University Medical Center of El PasoEl PasoTexas79905
Leann Rodriguez
[email protected]
(915) 215-4976
Edward A Michelson, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in El Paso, TX

By condition
Migraine
By specialty
Neurology
By research site
University Medical Center of El Paso· El Paso, TX

Related Studies